SunWay Biotech Co

SunWay Biotech Co Assets per Share

The Total Assets per Share of SunWay Biotech Co (1271.TWO) as of Oct 21, 2026 is 73.88 TWD. In the previous year, Total Assets per Share was 62.80 TWD — a change of 17.65% (higher).

Assets per Share

73.88TWD

YoY

17.65%

Last updated:

Total Assets per Share of SunWay Biotech Co is 2025 73.88 TWD. Total Assets per Share of SunWay Biotech Co was 2024 62.80 TWD. It decreases by 17.65% higher compared to the previous year.

The SunWay Biotech Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2019
5.26 TWD
Jan 1, 2020
8.46 TWD
Jan 1, 2021
10.06 TWD
Jan 1, 2022
7.92 TWD
Jan 1, 2023
60.53 TWD
Jan 1, 2024
62.80 TWD
Jan 1, 2025
73.88 TWD
The SunWay Biotech Co Assets per Share history
YEARAssets per ShareYoY
73.88TWD+17.65%
62.80TWD+3.75%
60.53TWD+664.38%
7.92TWD-21.30%
10.06TWD+18.89%
8.46TWD+61.05%
5.26TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SunWay Biotech Co Stock analysis

What does SunWay Biotech Co do? SunWay Biotech Co., Ltd. generates revenue through the research, development, manufacture, and sale of red yeast health food products. The company's main products include Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which target digestive health, bacterial ecology regulation, immunity, and allergy management. These products are sold in both domestic and overseas markets, catering to consumers seeking natural health solutions. The firm focuses on health food segments where digestive and immune support are key consumer needs. The company's product portfolio emphasizes specific strains like Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which are marketed for their functional benefits in digestion and immune regulation. These health foods are distributed across domestic and international channels, targeting health-conscious consumers who prioritize natural remedies. SunWay Biotech leverages its research-driven approach to position these products in the health food market. SunWay Biotech Co., Ltd. operates within the health food industry, focusing on products that address digestive and immune health through natural ingredients. Its offerings are designed to improve bacterial ecology in the digestive tract and regulate immunity and allergies, appealing to a segment of consumers interested in preventive health solutions. The company's domestic and overseas market strategy ensures broad reach for its specialized health food products. SunWay Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SunWay Biotech Co stock

Total Assets per Share of SunWay Biotech Co is 73.88 TWD in 2025.

Total Assets per Share of SunWay Biotech Co changed from 62.80 TWD to 73.88 TWD, representing a 17.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share SunWay Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — SunWay Biotech Co

All Key Metrics — SunWay Biotech Co